Literature DB >> 35301509

STINGing type I IFN-mediated immunopathology in COVID-19.

Evangelos Andreakos1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35301509     DOI： 10.1038/s41590-022-01174-6

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  2 in total

1.  Ni-electrocatalytic Csp3-Csp3 doubly decarboxylative coupling.

Authors:  Benxiang Zhang; Yang Gao; Yuta Hioki; Martins S Oderinde; Jennifer X Qiao; Kevin X Rodriguez; Hai-Jun Zhang; Yu Kawamata; Phil S Baran
Journal:  Nature       Date:  2022-04-05       Impact factor: 69.504

Review 2.  The type I interferonopathies: 10 years on.

Authors:  Yanick J Crow; Daniel B Stetson
Journal:  Nat Rev Immunol       Date:  2021-10-20       Impact factor: 108.555
  2 in total
  3 in total

Review 1.  Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy.

Authors:  Mahdi Eskandarian Boroujeni; Agata Sekrecka; Aleksandra Antonczyk; Sanaz Hassani; Michal Sekrecki; Hanna Nowicka; Natalia Lopacinska; Arta Olya; Katarzyna Kluzek; Joanna Wesoly; Hans A R Bluyssen
Journal:  Front Immunol       Date:  2022-05-17       Impact factor: 8.786

2.  Surrogate cytokine agonists: promising agents against COVID-19.

Authors:  Zemin Lin; Jianping Zuo; Shijun He
Journal:  Signal Transduct Target Ther       Date:  2022-05-06

Review 3.  T Cell Extracellular Traps: Tipping the Balance Between Skin Health and Disease.

Authors:  Kelsey Ouyang; Nicole Oparaugo; Amanda M Nelson; George W Agak
Journal:  Front Immunol       Date:  2022-06-20       Impact factor: 8.786
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.